基于术前MRI的肝门部胆管癌根治术后生存预测列线图的开发与验证:一项初步研究
该研究纳入184例接受根治性切除及术前MRI的肝门部胆管癌患者,随机分为建模组110例和测试组74例,基于术前CEA、cN分期、肝动脉侵犯及影像组学特征构建两个列线图预测总生存。临床模型在训练集和测试集的C-index分别为0.846和0.755,联合影像组学模型分别为0.962和0.814,两者均优于TNM分期系统,校准曲线和决策曲线显示良好一致性及临床实用性。
要点
- 术前MRI影像组学联合临床模型(CEA、cN分期、肝动脉侵犯)可预测肝门部胆管癌根治术后1、3、5年总生存。
- 联合模型在训练集和测试集的C-index分别为0.962和0.814,均优于TNM分期系统。
- 列线图基于 multivariable Cox 比例风险方法构建,校准曲线显示良好一致性,决策曲线显示临床实用性。
关键影像表现/征象
- 临床模型基于三个独立变量:术前CEA、cN分期、影像上肝动脉侵犯。
- 最佳性能模型(Modelclinic&AP&PVP)使用三个独立变量:SignatureAP、SignaturePVP及临床变量?原文表述为「using three independent variables, SignatureAP and SignaturePVP」,可能遗漏一个临床变量,但原文只列出两个签名,故照录。
- 影像上可见的肝动脉侵犯是临床模型的独立预测因子之一。
诊断标准与关键数值
- 联合模型(Modelclinic&AP&PVP)在训练集C-index为0.962(95%CI 0.905-1),测试集为0.814(95%CI 0.569-1)。
- 两个模型均优于TNM分期系统;校准曲线显示良好 agreement,决策曲线显示 favorable clinical utility。
临床应用与阅片要点
- 术前MRI评估肝门部胆管癌时,应关注肝动脉侵犯征象并纳入报告。
- 可结合术前CEA、cN分期及影像组学特征使用列线图预测术后生存,辅助临床决策。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aim to develop survival predictive tools to inform clinical decision-making in perihilar cholangiocarcinoma (pCCA).
MATERIALS AND METHODS: A total of 184 patients who had curative resection and magnetic resonance imaging (MRI) examination for pCCA between January 2010 and December 2018 were enrolled. 110 patients were randomly selected for model development, while the other 74 patients for model testing. Preoperative clinical, laboratory, and imaging data were analyzed. Preoperative clinical predictors were used independently or integrated with radiomics signatures to construct different preoperative models through the multivariable Cox proportional hazards method. The nomograms were constructed to predict overall survival (OS), and the performance of which was evaluated by the discrimination ability, time-dependent receiver operating characteristic curve (ROC), calibration curve, and decision curve.
RESULTS: The clinical model (Modelclinic) was constructed based on three independent variables including preoperative CEA, cN stage, and invasion of hepatic artery in images. The model yield the best performance (Modelclinic&AP&PVP) was build using three independent variables, SignatureAP and SignaturePVP. In training and testing cohorts, the concordance indexes (C-indexes) of Modelclinic were 0.846 (95 % CI, 0.735-0.957) and 0.755 (95 % CI, 0.540-969), and Modelclinic&AP&PVP achieved C-indexes of 0.962 (95 % CI, 0.905-1) and 0.814 (95 % CI, 0.569-1). Both Modelclinic and Modelclinic&AP&PVP outperformed the TNM staging system. Good agreement was observed in the calibration curves, and favorable clinical utility was validated using the decision curve analysis for Modelclinic and Modelclinic&AP&PVP.
CONCLUSION: Two preoperative nomograms were constructed to predict 1-, 3-, and 5-years survival for individual pCCA patients, demonstrating the potential for clinical application to assist decision-making.
引用
- Zhao J, Zhang W, Fan CL, et al. Development and validation of preoperative magnetic resonance imaging-based survival predictive nomograms for patients with perihilar cholangiocarcinoma after radical resection: A pilot study. Eur J Radiol. 2021. PMID: 33711571. doi:10.1016/j.ejrad.2021.109631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。